FisclearFisclear

Financial Comparison

Divi's Laboratories Limited vs Sun Pharmaceutical Industries Limited

Click a ticker to view the full analysis.

DIVISLAB.NS vs

In short

Divi's Laboratories Limited is the more profitable of the two, keeping 24.5% of revenue as net profit against 19.7% for Sun Pharmaceutical Industries Limited. Divi's Laboratories Limited trades at the higher trailing P/E (85.0× vs 35.2× for Sun Pharmaceutical Industries Limited), so investors pay more for each dollar of its earnings. Fisclear flags 1 medium- or high-severity risk for Divi's Laboratories Limited and 0 for Sun Pharmaceutical Industries Limited.

Based on filings for periods ending 31 Mar 2026 (DIVISLAB.NS) and 31 Mar 2026 (SUNPHARMA.NS) · Updated

FisclearScore Comparison

DIVISLAB.NS55Fair
SUNPHARMA.NS68Strong
Quality+11
83
94
Efficiency
62
62
Value+36
26
62
Cashflow+17
39
56
Regime
55
55
Peers+12
58
70

FisclearScore is a quantitative model. DIVISLAB.NS shown solid · SUNPHARMA.NS shown dashed. Not financial advice.

MetricDIVISLAB.NSSUNPHARMA.NS
Price₹9,363.50₹1,772.00
Market Cap₹2.49T₹4.25T
P/E (TTM)85.0x35.2x
P/B14.8x5.1x
Beta0.230.14
Div Yield0.32%0.91%
Revenue (TTM)₹104.8B₹582.2B
Net Income₹25.7B₹114.8B
Gross Margin59.1%77.4%
Risk Flags1 flag—
Full DIVISLAB.NS Report →Full SUNPHARMA.NS Report →

Related comparisons

Dr. Reddy's Laboratories vs Sun PharmaceuticalCIPLA.NS vs Sun PharmaceuticalAPOLLOHOSP.NS vs Sun PharmaceuticalSun Pharmaceutical vs TORNTPHARM.NSDIVISLAB.NS vs Dr. Reddy's LaboratoriesCIPLA.NS vs DIVISLAB.NS

Data sourced from SEC EDGAR, Yahoo Finance, and official exchange filings. For informational purposes only. Not financial advice.